Ishita Drugs Shows Mixed Financial Performance Amid Shift in Market Sentiment
Ishita Drugs & Industries has recently adjusted its technical outlook, shifting from bearish to mildly bearish. The company reported a 32.27% increase in net sales for the latest quarter, achieving its highest quarterly profit after tax. However, long-term fundamentals show some weaknesses, including a modest return on equity.
Ishita Drugs & Industries has recently undergone an adjustment in evaluation, reflecting a shift in its technical outlook. The stock's technical trend has transitioned from bearish to mildly bearish, indicating a nuanced change in market sentiment. Key financial metrics reveal that Ishita Drugs has experienced a positive performance in its latest quarter, with net sales reaching Rs 9.96 crore, marking a growth of 32.27%. Additionally, the company reported its highest quarterly profit after tax (PAT) at Rs 0.30 crore and a peak in profit before depreciation, interest, and taxes (PBDIT) at Rs 0.35 crore. Despite these positive indicators, the company's long-term fundamentals show some weaknesses, including an average return on equity (ROE) of 8.40% and a modest annual growth rate in net sales of 5.54% over the past five years.
The stock has generated a return of -6.10% over the last year, underperforming against broader market indices. However, it is trading at a discount compared to its peers' average historical valuations, with a price-to-book value of 2.1.
For more insights on Ishita Drugs & Industries and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
